
EASD 2025
The GLP1-Receptor Agonist Semaglutide As an Adjunct to a Lifestyle Intervention in the Treatment of Type 2 Diabetes: Effects on Glucose Metabolism
The trial study was presented on Monday, September 15th, 2025

The trial study was presented on Monday, September 15th, 2025

Women undergoing frozen embryo transfer in natural cycles who experience

Women who experience complete embryo developmental arrest where none of

Women with a history of pregnancy loss show significantly elevated

Commercial artificial intelligence systems used to assist with embryo selection

The type of chromosomal structural rearrangement a person carries has